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Abstract
Currently,  DNA  amplification  techniques  have  become  important  detection  tools.
However, the extreme sensitivity of such techniques can easily result in contamination.
This is a major problem in using these techniques routinely in a regulatory agency such
as the Food and Drug Administration (FDA) because false-positive polymerase chain
reaction (PCR) results will fail our mission. Preventing PCR carryover contamination
and a capacity to rapidly determine false PCR positives are crucial. In the past, several
methods have been used to prevent amplicon carryover contamination. In this chapter,
we  provide  practical  suggestions  for  PCR  carryover  contamination  detection  and
prevention that work well with most PCR applications in our laboratory.
Keywords: polymerase chain reaction (PCR), carryover contamination, nested PCR,
real-time PCR, single-tube nested real-time PCR
1. Introduction
Polymerase chain reaction (PCR) amplification techniques have provided means for the rapid
and sensitive detection of pathogens [1]. The number of applications of PCR is still growing,
and more and more amplification-based techniques are now used in FDA field laboratories
to detect pathogens, such as Salmonella, Escherichia coli 0157:H7, Shigella, Vibrio, hepatitis A
virus  (HAV)  and  noroviruses  (NoVs)  [2].  A  significant  challenge  facing  us  is  that  the
sensitivity of PCR can easily result in contamination and consequently in false-positive PCR.
A small  amount of previously amplified PCR product or potential  target sequences that
infiltrate laboratory supplies and equipment or that  are present in an aerosol  can easily
contaminate the sample and PCR reagents in the tests. Therefore, prevention of carryover
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contamination from previous PCR amplifications has become a high priority. As a first line
of defense to prevent contamination of PCR with a previously generated amplicon, mechan-
ical separation of the PCR laboratory into different rooms or laboratory benches is needed.
Secondly,  chemical,  UV,  and  enzymatic  methods  can  be  applied  to  inactivate  any  prior
amplicon generated in the laboratory. Additionally, rapid identification of contaminants and
their sources is needed to prevent false-positive PCR results. For this purpose, we developed
a rapid method to detect PCR carryover contamination by DNA sequencing. The combination
of the above methods plus good laboratory technique should be able to totally eliminate PCR
carryover contamination and allow us to perform accurate and sensitive PCR routinely in
regulatory setting.
1.1. Polymerase chain reaction
In 1983, Dr. Kary Mullis at Cetus Corporation conceived of polymerase chain reaction. There
is not any technique that has had a greater impact on the practice of molecular biology than
PCR. PCR-based methods are powerful techniques [3]. This technique is centered around the
ability of sense and anti-sense DNA primers to hybridize to a DNA of interest. When put into
use, agents of infectious diseases can be detected at extremely low levels. After extension from
the primers on the DNA template by DNA polymerase, the reaction is heat-denatured and
allowed once again, to anneal with the primers. After another round of extension, a multipli-
cative increase in DNA products is observed. When critical controls are set, this technique
becomes a quantitative process. Therefore, a minute amount of DNA can be efficiently
amplified in an exponential fashion to result in an easily manipulable amount of DNA. The
current sensitivity and detection limit is at a level as low as 10–50 copies per ml. Although the
PCR is extremely easy and fast, PCR product carryover contamination impedes the routine
use of these techniques routinely in regulatory laboratories.
1.2. PCR-based technology
1.2.1. Reverse transcription PCR (RT-PCR)
PCR uses DNA as a starting material. When RT-PCR is carried out, the starting material is
RNA. In this method, RNA is first transcribed into complementary DNA (cDNA) by reverse
transcriptase from total RNA or messenger RNA (mRNA). The cDNA is then used as a
template for the quantitative PCR (qPCR). Real-time quantitative PCR (RT-qPCR) is used in a
variety of applications such as food-borne RNA virus and avian flu virus detection. With this
technique, we can detect the target RNA at an extremely low level in samples. RT-PCR is an
increasingly popular method for RNA virus detection, but DNA contamination in RNA
preparations is also a concern. In order to minimize the possibility of carryover contamination
in RT-PCR, it is critical to minimize the number of handling and pipetting steps.
1.2.2. Real-time quantitative PCR (qPCR)
Traditional detection of amplified PCR product relies upon gel electrophoresis. qPCR is an
advanced form of the traditional PCR. It is a major development in PCR technology that enables
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the reliable detection and measurement of products generated during every cycle of the PCR
process. This technique became possible after the introduction of an oligonucleotide probe that
was designed to hybridize within the target sequence. Due to the 5′ nuclease activity of Taq
polymerase, amplification of the target-specific product can be detected through cleavage of
the probe during PCR. These assays are very sensitive and can detect as few as 10–100 viral
copies per reaction. qPCR techniques have evolved into a variety of other branches including
real-time PCR by Taqman (Roche), LightCycler by (Roche), SmartCycler by (Cepheid), etc.
Some of them are now widely in use for virus and bacteria detection in regulatory laboratories.
Unlike other PCR methods, qPCR does not require post-PCR product handling, preventing
potential PCR product carryover contamination.
1.3. PCR contamination
All the PCR methods are powerful techniques. Unfortunately, the exquisite sensitivity of these
techniques makes them vulnerable to contamination [4, 5]. One of the most important rules
when performing PCR is to avoid contamination. This chapter will outline necessary precau-
tions to prevent contamination as well as procedures for detecting and cleaning suspected
contamination.
2. Potential sources of contamination
2.1. Cross contamination between samples
A large number of target organisms in sample handling may lead to pre-amplification sample
cross contamination [6, 7]. The sources of contaminants between samples are diverse and can
all contribute to the contamination of the finished PCR product. These sources may include
reagents, disposable supplies, sample carryover, improper handling procedures, etc.
2.2. Cross contamination between nucleic acids
Cross contamination between nucleic acids is a major problem in all PCR laboratories. Nucleic
acids from organisms or plasmid clones derived from organisms that have been previously
analyzed and that may be present in large numbers in the laboratory environment could be a
source of contamination. Contaminants can also be introduced by unrelated activities in
neighboring laboratories. These sources of contamination are problematic as they may lead to
pre-amplification cross contamination [8–10].
2.3. PCR product carryover contamination
The most important source of contamination is from the repeated amplification of the same
target sequence, which leads to accumulation of amplification products in the laboratory
environment. Even minute amounts of carryover can lead to false-positive results. A typical
PCR generates theoretically as many as 108 copies of target sequence [11]. If uncontrolled,
amplification products will contaminate laboratory reagents, equipment, and ventilation
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systems. Carryover of previously accumulated amplified DNA is considered the major source
of contamination.
3. Methods to control contamination
Contamination between samples and from previous PCR amplicon generation is a significant
potential source of invalid PCR results [12]. The first two forms of contamination described
above can be easily avoided by using careful technique and good quality control practices.
Generally, most PCR-based assays consist of three steps: DNA sample processing, PCR
amplification, and amplification product detection (excluding real-time PCR). It is in the latter
step that carryover contamination often occurs through methods that include gel electropho-
resis, solid phase hybridization, solution hybridization, and capillary electrophoresis [7].
Methods to prevent amplification product carryover contamination have been developed in
the past ten years [13–17]. Basically, there are mechanical, chemical, UV light irradiation, and
enzymatic methods and closed-tube PCR detection formats, all of which can help to prevent
amplification product carryover contamination [7]. The following section will focus on more
recent practices and methods that have been used in our laboratory to eliminate carryover
contamination.
3.1. Mechanical method
Our laboratory was designed and operated in a way that prevents contamination of reactions
with PCR products from previous assays and cross contamination between samples. It includes
the separation of areas of the laboratory where samples and reagents are prepared from the
areas where amplification is performed and amplification products are analyzed. This
unidirectional workflow can reduce the opportunity for contamination to occur. A typical PCR
laboratory should be divided into at least three to four different areas—(1) sample preparation,
(2) PCR mix preparation, (3) PCR product detection, and (4) RNase free area—if the PCR
method involves RNA sample.
3.2. Chemical method
General cleaning practices are important for controlling PCR carryover contamination. All
surfaces in the PCR area should be routinely decontaminated to prevent cross contamination.
The PCR work bench is required to be cleaned with 10–15 % sodium hypochlorite solution
(bleach), followed by removal of the bleach with 70 % ethanol.
3.3. UV irradiation method
UV irradiation is an easy method to inactivate amplification product involved in carryover
contamination. The method is based on the ability of UV light to induce thymidine dimer
formation in the DNA that makes the contaminating nucleic acid inactive as a template for
further amplification (Figure 1). A good practice is to expose all of the PCR supplies to UV
light for 5–20 min as the nucleic acid will be damaged by absorbing the UV light energy at
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254 nm wavelength [19]. UV irradiation is an integral feature of our PCR laboratory, and the
Spectrolinker XL-1500 (Spectronics Corporation, Westbury, NY) is used to eliminate contam-
ination that may occur during PCR tests. All of our PCR tools are stored in a UV light box
(C.B.S Scientific, Co. Del Mar, Ca). PCR master mix preparation and specimen setup are also
carried out in this UV light box.
Figure 1. Action of UV light on the nucleic acids [18].
3.4. Enzymatic method
Uracil-DNA glycosylase (UNG) is a DNA repair enzyme [20] that can recognize and remove
uracil residues from DNA (Figure 2). In 1990, the use of UNG to inactivate PCR products was
first reported [21]. This method employs uracil (dUTP) instead of thymine (dTTP) during PCR
to generate amplification products with distinguishing characteristics relative to the native
DNA template. Because the newly synthesized amplicons contain dUTP, they are susceptible
to hydrolysis by UNG. This method is the most widely used contamination control technique
in our laboratory.
Figure 2. Replace dTTP with dUTP during PCR amplification and the PCR product will contain uracil. Prior to PCR,
the PCR mixture is treated with uracil-DNA glycosylase (UNG). During the denaturation step, temperature is elevated
to 95°C, resulting in cleavage of apyrimidinic sites and fragmentation of carryover DNA. As the template contains thy-
midine, it will not be affected by the UNG treatment (source: Sopachem Life Sciences).
Regulatory Concern of Polymerase Chain Reaction (PCR) Carryover Contamination
http://dx.doi.org/10.5772/66294
61
Briefly, this carryover prevention technique consists of three steps:
1. The dUTP is incorporated into all PCR products, substituting dUTP for dTTP or incorpo-
rating dUTP during synthesis of the primers [15, 22].
2. Before PCR, mixtures are treated with UNG (Applied Biosystems, Foster City, CA) at room
temperature for 10 min to hydrolyze and remove any contaminating amplification
products that may be present in the PCR mixtures. This technique also has a hot start
function [15].
3. UNG is thermally inactivated at 95°C for 5 min prior to the actual PCR.
3.5. Another amplification format without the risk of carryover contamination
3.5.1. Real-time PCR-based technology to avoid contamination
In traditional PCR, amplification and detection of the target DNA sequence occur separately.
To determine if a sample contains the target sequence, post-amplification handling of the
amplicon is required. A more recent technological development, real-time PCR [23], allows for
the simultaneous amplification and detection of a target sequence through the use of fluores-
cent-labeled probes (Figure 3). In comparison to conventional PCR, real-time PCR can reduce
the chance of carryover contamination. The new generation of amplification technology
simultaneously amplifies and detects target DNA without exposing the amplification products
to the laboratory environment. Currently, we developed several real-time PCR methods, such
as single-tube real-time PCR and single-tube nested real-time PCR (Figure 4) to simultaneously
detect multiple pathogens in a closed system which has substantially reduced the possibility
of false-positive results due to amplification product carryover contamination [24, 25].
Figure 3. A typical result of graphical view from our laboratory.
Polymerase Chain Reaction for Biomedical Applications62
Figure 4. Single closed-tube nested real-time-PCR system: in order to reduce the chance of carryover contamination, all
reactions including reverse transcription, conventional PCR, first PCR, nested PCR, and real-time TaqMan detection
are performed in a single closed tube [24].
4. Method to detect contamination
In the context of this discussion, contamination is defined as the unwanted presence of a PCR
amplicon. At times, PCR contamination is present but difficult to ascertain. If a significant
contamination problem appears in a PCR laboratory, we need to walk through the procedure
of testing for contamination and, if necessary, replace all reagents. The PCR parameters
considered for potential sources of contamination include amplification setup, amplification
product handling, and DNA aerosol and storage. Carryover contamination is determined by
the following methods in our laboratory.
4.1. Internal controls
Appropriate control reactions are helpful in determining whether DNA contamination has
occurred. It is important to use a special PCR-positive control which is different from the
sample DNA, such as a DNA fragment with a deletion or base alteration in the region of
amplification [26]. PCR products can be assessed on a gel to distinguish the control from the
native PCR products. Negative controls are also very important and must be included with
each run because the first sign of contamination trouble is usually the appearance of an
amplification product in the negative or blank controls [27].
4.2. DNA sequencing
Techniques to sequence PCR products were developed in our laboratory in the past few years
[15, 28]. This confirmatory sequencing ensures that the PCR product has the expected se-
quence. The direct comparison of PCR product sequences from a sample and a control is the
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best way to determine whether two PCR products are similar or different. After comparison
of the DNA sequence variation between the PCR products and the control, the cross contam-
ination of samples can be detected. In some suspected cases, we directly sequenced PCR
products by using the ABI BigDye Terminator Cycle Sequencing kit with a 3500 Genetic
Analyzer (Applied Biosystems, Foster City, CA, USA) according to the manufacturer’s
instructions. Briefly, each cycle consists of denaturation at 96°C for 10 s, annealing at 50°C for
5 s, and extension at 60°C for 4 min. After 25 cycles, the fluorescent extension products are
purified by a simple isopropanol precipitation step. Software is available on websites [29] to
perform a wide range of different types of sequence alignment. DNA sequence data were
analyzed by the Geneious, the GenBank sequence database, and the BLAST program from the
National Center for Biotechnology Information (NCBI). Accurate identification of any
contamination is required for the proper function of FDA field laboratory. The DNA sequenc-
ing method should be an ideal technology for this purpose.
5. Discussion
PCR is a very powerful and extremely sensitive amplification technique, but there is always
the peril that a tiny amount of contamination of the DNA target may lead to false-positive
results. It has become necessary to systematically address the issue of PCR contamination,
especially in the FDA, a regulatory agency. To overcome this issue, effective methods have
been successfully developed and used to avoid carryover contamination in our regulatory
laboratories in the past few years [15, 24, 25].
• We have effectively established and maintained a unidirectional workflow from a PCR clean
to a PCR dirty area, thereby reducing the opportunity of contamination to occur.
• Samples were set up on a bench that was isolated from PCR product testing areas.
• All PCR master mixes were prepared in a separate room or at least on a separate bench.
Also, we always used a separate laboratory coat, gloves, tubes, and filter pipette tips in the
different PCR working areas.
• A separate aliquot of water stock for each round of PCR was addressed.
• All PCR work benches were decontaminated with 10–15 % bleach and 70 % alcohol. All the
pipettes, pipette tips, tubes, racks, and gloves were UV-irradiated.
• A different pipette tip was used when pipetting each of the PCR reagents, even the same
master mix to each tube.
• The PCR tubes were kept closed during the procedure. The tubes were opened only when
necessary because of potential aerosols that are dangerous with respect to contamination.
Minimizing the number of pipetting and mixing steps in PCR master mix preparation is also
very important from the perspective of aerosol contamination.
• It is very important to schedule PCR when not handling plasmids to prevent cross contam-
ination.
Polymerase Chain Reaction for Biomedical Applications64
• dUTP was incorporated into all PCR products which can subsequently be selectively
destroyed by UNG.
• Optimization of PCRs is also important. G + C-rich products may be more difficult to
inactivate by UNG because of the lower concentration of uridine triphosphate(UTP).
• Positive controls consisted of a low copy number of the desired nucleic acid target and
should never be prepared or stored with the samples.
• Other amplification methods, such as real-time PCR [23] or closed-tube PCR [25] which can
reduce the chances of carryover contamination, are now being used more routinely in our
laboratory.
• A rapid DNA sequencing method to precisely detect contamination was established.
6. Conclusion
Standard precautions should always be employed during all PCR-based testing, whether it
is real-time PCR or conventional PCR. All the regulatory laboratories should have their own
appropriate controls and systematic measures to prevent and detect contamination. When
contamination does occur, we need to accurately determine which reagent is contaminated.
All of us should also understand that our individual working habits directly affect our work
quality. We believe all the above methods can reduce the risk of contamination and ensure
the efficacy of all PCR results.
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